Full text is available at the source.
Abstract
Nicotinamide riboside has been proposed as a potential disease-modifying therapy for Parkinson disease.
- Nicotinamide riboside is a precursor to nicotinamide adenine dinucleotide.
- Preclinical and early studies suggest it may have therapeutic potential in Parkinson disease.
- The effect of prolonged oral nicotinamide riboside on clinical outcomes in Parkinson disease is currently unknown.
Simplified
Longevity & Aging